TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 32 | 14 | -12 | -20 | -56 | -26 | -11 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/31/16 16:37 | 10/27/16 | CNAT | Conatus Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Wart Harold | CA | D | M.d | 5 | 0.2500 | 1 | 18 | New | 18 | D | -78 | -56 | -37 | -25 | -2 | -14 | -11 | -15 | -11 | -13 | 5 | 149 | 387 | ||
5/19/15 19:44 | 5/18/15 | CBAY | Cymabay Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Van Wart Harold | CA | DO | P,CEO | P | 25 | 3.34 | 0 | 8 | 999% | 8 | D | -58 | -57 | -73 | -49 | -26 | -14 | 16 | 32 | 14 | -12 | -20 | -56 | -26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |